 Connection
Robert Page to Heart Transplantation
This is a "connection" page, showing publications Robert Page has written about Heart Transplantation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.305 |
|
|
|
-
Page RL, Luna M, Brieke A, Lindenfeld J. Low-dose gabapentin for intractable hiccups in a heart transplant recipient. Prog Transplant. 2011 Dec; 21(4):340-3.
Score: 0.241
-
Rao M, Page RL, Sartain E. Twelve-Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol. Clin Transplant. 2025 Apr; 39(4):e70147.
Score: 0.152
-
Page RL, Miller GG, Lindenfeld J. Drug therapy in the heart transplant recipient: part IV: drug-drug interactions. Circulation. 2005 Jan 18; 111(2):230-9.
Score: 0.150
-
J Ilonze O, Knapp SM, Chernyak Y, Page RL, Boyd LJ, Mazimba S, Raman SV, Enyi CO, Allen LA, Breathett K. Cannabis use and heart transplant listing: A survey of clinician practices. PLoS One. 2024; 19(12):e0310778.
Score: 0.149
-
Fraser M, Page RL, Chow S, Alexy T, Peters L. Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists. Clin Transplant. 2024 02; 38(2):e15252.
Score: 0.140
-
Jurgens PT, Aquilante CL, Page RL, Ambardekar AV. Perioperative Management of Cardiac Transplant Recipients Undergoing Noncardiac Surgery: Unique Challenges Created by Advancements in Care. Semin Cardiothorac Vasc Anesth. 2017 Sep; 21(3):235-244.
Score: 0.088
-
Bryant BM, Libby AM, Metz KR, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients. Ann Pharmacother. 2016 11; 50(11):926-934.
Score: 0.083
-
Deininger KM, Vu A, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. Clin Transplant. 2016 09; 30(9):1074-81.
Score: 0.083
-
Aquilante CL, Page RL, Vu A, Roscoe N, Wolfel EE, Lindenfeld JA. Comparison of office, home, and ambulatory blood pressure in heart transplant recipients. J Card Fail. 2014 Aug; 20(8):602-10.
Score: 0.071
-
Lindenfeld J, Page RL, Zolty R, Shakar SF, Levi M, Lowes B, Wolfel EE, Miller GG. Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation. 2005 Jan 04; 111(1):113-7.
Score: 0.037
-
Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation. 2004 Dec 21; 110(25):3858-65.
Score: 0.037
-
Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation. 2004 Dec 14; 110(24):3734-40.
Score: 0.037
-
Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
Score: 0.021
-
Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013 May; 19(5):354-69.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|